Shishan Deng

Nanchong, 637000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Multi-Omics Integration Identifies the Cholesterol Metabolic Enzyme DHCR24 as a Key Driver in Breast Cancer.

Multi-Omics Integration Identifies the Cholesterol Metabolic Enzyme DHCR24 as a Key Driver in Breast Cancer.

Journal: Biology

Published: November 17, 2025

A selective RCC1 inhibitor loaded in membrane-coated DNA nanocage for targeted suppression of TNBC progression.

A selective RCC1 inhibitor loaded in membrane-coated DNA nanocage for targeted suppression of TNBC progression.

Journal: Materials today. Bio

Published: July 05, 2025

A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression.

A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression.

Journal: Materials today. Bio

Published: November 14, 2024

The risk of heart-specific death in breast cancer patients.

The risk of heart-specific death in breast cancer patients.

Journal: Scientific reports

Published: November 01, 2024

The crosstalk of breast cancer and ischemic heart disease.

The crosstalk of breast cancer and ischemic heart disease.

Journal: Cell death discovery

Published: August 06, 2024

DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway.

DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway.

Journal: Discover oncology

Published: April 19, 2023

The involvement of high succinylation modification in the development of prostate cancer.

The involvement of high succinylation modification in the development of prostate cancer.

Journal: Frontiers in oncology

Published: September 01, 2022

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses.

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses.

Journal: Frontiers in molecular biosciences

Published: July 02, 2022

Targeted Intervention of NF2-YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC.

Targeted Intervention of NF2-YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC.

Journal: ACS nano

Published: April 14, 2022

Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications.

Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 22, 2022

Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.

Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: April 26, 2021

The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.

The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.

Journal: Gland surgery

Published: January 16, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026